moderna vaccine - Search News

Order byBest matchMost fresh

HHS cancels funding for Moderna bird flu vaccine

U.S. Cancels Contract With Moderna to Develop Bird Flu Vaccine

The Trump administration has delivered its latest blow to vaccines, canceling a nearly $600-million contract to the drugmaker Moderna that was intended to develop a shot for humans against bird flu.

· 23h

U.S. Ends $600M Moderna Bird Flu Vaccine Contract

· 1d · on MSN

HHS cancels $590 million contract with Moderna for bird flu vaccine

· 23h

Trump administration cancels $766 million Moderna contract to fight future pandemics, including bird flu

The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.

· 13h

Trump Administration Cancels $600 Million Contract to Develop Bird Flu Vaccine

NBC Los Angeles · 23h

Live updates: Trump appeals trade court tariff ruling; HHS cancels funding for Moderna bird flu vaccine

· 1d

Moderna Announces Update on Investigational Pandemic Influenza Program

Moderna received notice that HHS will terminate the award for the late-stage development and right to purchase pre-pandemic influenza vaccines.

· 21h

RFK Jr. yanks pandemic vaccine funding as Moderna reports positive results

STAT · 1d

HHS cancels nearly $600 million Moderna contract on vaccines for flu pandemics

STAT17h

Moderna’s vaccine hit, the MAHA report, and an ASCO preview

On this week's podcast, STAT's Helen Branswell talks about BARDA cancelling its contract with Moderna and RFK Jr. taking an unprecedented move on Covid shots.

Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 formula,

US Cancels More $700 Million Funding for Moderna Bird Flu Vaccine

This was in addition to $176 million awarded by the U.S. Department of Health and Human Services last year to complete the late-stage development and testing of a pre-pandemic mRNA-based vaccine against the H5N1 avian influenza. Moderna said it plans to explore alternatives for late-stage development and manufacturing of the vaccine.

Infectious Disease Advisor2d

Moderna Withdraws BLA for Flu/COVID-19 Combo Vaccine Candidate

Moderna has withdrawn the BLA for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after consulting with FDA.